BY MARKETWIRE
-
Eli Lilly targets fast-track US review for weight loss pill
According to the United States pharmaceutical business, the weight-loss tablet fulfills 3 out of 4 standards for the FDA’s brand-new nationwide concern coupon.
-
Italian hearing aid retailer dives after another disappointing quarter
Italian listening devices seller Amplifon’s economic outcomes have likewise had an effect on Danish hearing firms.
-
Analyst: Eli Lilly’s growth worries Novo investors but may be a positive indicator for next week’s financial results
Eli Lilly shows up to have energy in sales of GLP-1 medicines, however expert Søren Løntoft Hansen from Sydbank likewise has actually elevated his assumptions for Danish Novo Nordi…
-
US pharma giant beats expectations and raises forecast
The most up to date medications are marketing well at Bristol Myers Squibb, while older items are seeing decreasing sales.
-
Novo Nordisk strikes back at Pfizer: Our bid is superior
Novo Nordisk turns down Pfizer’s cases that the Danish business’s quote breaks the United States business’s arrangement with Metsera or competitors regulation aro…
-
Eli Lilly targets fast-track US review for weight loss pill
According to the US pharmaceutical company, the weight loss pill meets three out of four criteria for the FDA’s new national priority voucher.
-
Lundbeck to present new data on acquired epilepsy drug soon
Lundbeck got Bexicaserin in 2014 about the acquisition of Longboard Pharmaceuticals.
-
GN eases investor concerns with half-year results
Jyske Financial institution analyzes that GN’s development energy in Hearing is back on course.
-
Ambus’ growing top line and weaker earnings offer a mixed impression, according to Sydbank
Ambu shares might come under stress after third-quarter revenues let down capitalist assumptions, according to equity expert Søren Løntoft Hansen.
-
GN sees uncertainty on several fronts after reports from competitor
Unfavorable records from Italy’s Amplifon add to uncommon unpredictability in advance of GN’s 2nd quarter results on Thursday.
